Maximum quantity allowed is 999
请选择数量
CAS RN: 15297-92-4 | 產品號碼: L0422
LDN-22684
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | L0422 |
純度/分析方法 | >98.0%(HPLC) |
分子式 / 分子量 | C__1__5H__1__2O__3 = 240.26 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 | 100MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 15297-92-4 |
Reaxys-RN | 181737 |
MDL編號 | MFCD00022286 |
產品規格
Appearance | White to Yellow to Orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 142.0 to 146.0 °C |
NMR | confirm to structure |
性質
熔點 | 145 °C |
GHS
相關法規
運輸資料
HS編碼* | 2932.99-000 |
Application
LDN-22684: A LRRK2 Inhibitor as a Useful Tool for the Study of Parkinson's disease
The leucine-rich repeat kinase 2 (LRRK2) is a large protein (2527 amino acids) with serine-threonine (Ser/Thr) protein kinase activity and autophosphorylation activity. It is highly expressed in many mammal tissues. Genetic mutations in the G2019S encoding portion of LRRK2 (LRRK2-G2019S) have been detected frequently in Parkinson's (PD) patients.1-3) As a result, LRRK2-G2019S is a promising therapeutic target for the treatment of PD. There are reports, that LDN-22684 inhibited LRRK2-G2019S and wild-type LRRK2 in the low micromole range.1,3) Therefore it is a useful tool for the study of PD. (The product is for research purpose only.)
References
- 1) Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models (a review)
- 2) Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors (a review)
- 3) Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2-Discovery of LRRK2 inhibitors
文章/手冊
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。